Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Repurposing available drugs for neurodevelopmental disorders: The fragile X experience.

Tranfaglia MR, Thibodeaux C, Mason DJ, Brown D, Roberts I, Smith R, Guilliams T, Cogram P.

Neuropharmacology. 2019 Mar 15;147:74-86. doi: 10.1016/j.neuropharm.2018.05.004. Epub 2018 May 4. Review.

PMID:
29792283
2.

Editorial: Human and Animal Models for Translational Research on Neurodegeneration: Challenges and Opportunities From South America.

Ibáñez A, Sedeño L, García AM, Deacon RMJ, Cogram P.

Front Aging Neurosci. 2018 Apr 6;10:95. doi: 10.3389/fnagi.2018.00095. eCollection 2018. No abstract available.

3.

The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases.

Hurley MJ, Deacon RMJ, Beyer K, Ioannou E, Ibáñez A, Teeling JL, Cogram P.

Pharmacol Ther. 2018 Aug;188:36-44. doi: 10.1016/j.pharmthera.2018.03.001. Epub 2018 Mar 4. Review.

PMID:
29514054
4.

Dementia in Latin America: Assessing the present and envisioning the future.

Parra MA, Baez S, Allegri R, Nitrini R, Lopera F, Slachevsky A, Custodio N, Lira D, Piguet O, Kumfor F, Huepe D, Cogram P, Bak T, Manes F, Ibanez A.

Neurology. 2018 Jan 30;90(5):222-231. doi: 10.1212/WNL.0000000000004897. Epub 2018 Jan 5. Review.

5.

Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D).

Gurney ME, Cogram P, Deacon RM, Rex C, Tranfaglia M.

Sci Rep. 2017 Nov 7;7(1):14653. doi: 10.1038/s41598-017-15028-x.

6.

Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease.

Altimiras F, Uszczynska-Ratajczak B, Camara F, Vlasova A, Palumbo E, Newhouse S, Deacon RM, Farias LA, Hurley MJ, Loyola DE, Vásquez RA, Dobson R, Guigó R, Cogram P.

Front Aging Neurosci. 2017 Mar 20;9:64. doi: 10.3389/fnagi.2017.00064. eCollection 2017. No abstract available.

7.

Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.

Deacon RMJ, Hurley MJ, Rebolledo CM, Snape M, Altimiras FJ, Farías L, Pino M, Biekofsky R, Glass L, Cogram P.

Genes Brain Behav. 2017 Sep;16(7):739. doi: 10.1111/gbb.12373. Epub 2017 May 12.

PMID:
28211606
8.

Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.

Deacon RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, Nachtigall FM, Santos LS, Tsolaki AG, Pednekar L, Kishore U, Biekofsky RR, Vasquez RA, Cogram P.

Curr Alzheimer Res. 2015;12(4):314-22.

PMID:
25817252
9.

NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome.

Deacon RM, Glass L, Snape M, Hurley MJ, Altimiras FJ, Biekofsky RR, Cogram P.

Neuromolecular Med. 2015 Mar;17(1):71-82. doi: 10.1007/s12017-015-8341-2. Epub 2015 Jan 23.

PMID:
25613838
10.

Distribution of AGG interruption patterns within nine world populations.

Yrigollen CM, Sweha S, Durbin-Johnson B, Zhou L, Berry-Kravis E, Fernandez-Carvajal I, Faradz SM, Amiri K, Shaheen H, Polli R, Murillo-Bonilla L, Silva Arevalo Gde J, Cogram P, Murgia A, Tassone F.

Intractable Rare Dis Res. 2014 Nov;3(4):153-61. doi: 10.5582/irdr.2014.01028.

11.

CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.

Ferraz-de-Souza B, Martin F, Mallet D, Hudson-Davies RE, Cogram P, Lin L, Gerrelli D, Beuschlein F, Morel Y, Huebner A, Achermann JC.

J Clin Endocrinol Metab. 2009 Feb;94(2):678-83. doi: 10.1210/jc.2008-1064. Epub 2008 Nov 4.

12.

Rap1 regulates the formation of E-cadherin-based cell-cell contacts.

Hogan C, Serpente N, Cogram P, Hosking CR, Bialucha CU, Feller SM, Braga VM, Birchmeier W, Fujita Y.

Mol Cell Biol. 2004 Aug;24(15):6690-700.

13.

Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.

Cogram P, Hynes A, Dunlevy LP, Greene ND, Copp AJ.

Hum Mol Genet. 2004 Jan 1;13(1):7-14. Epub 2003 Nov 12.

PMID:
14613966
14.

D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects.

Cogram P, Tesh S, Tesh J, Wade A, Allan G, Greene ND, Copp AJ.

Hum Reprod. 2002 Sep;17(9):2451-8.

PMID:
12202440
15.

Sonic hedgehog and the molecular regulation of mouse neural tube closure.

Ybot-Gonzalez P, Cogram P, Gerrelli D, Copp AJ.

Development. 2002 May;129(10):2507-17.

16.

Neurulation and neural tube closure defects.

Copp A, Cogram P, Fleming A, Gerrelli D, Henderson D, Hynes A, Kolatsi-Joannou M, Murdoch J, Ybot-Gonzalez P.

Methods Mol Biol. 2000;136:135-60. Review. No abstract available.

PMID:
10840706

Supplemental Content

Loading ...
Support Center